| __timestamp | Ascendis Pharma A/S | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 13983000 | 26551000 |
| Thursday, January 1, 2015 | 8118000 | 50286000 |
| Friday, January 1, 2016 | 4606000 | 81321000 |
| Sunday, January 1, 2017 | 1530000 | 159201000 |
| Monday, January 1, 2018 | 10581000 | 251247000 |
| Tuesday, January 1, 2019 | 13375000 | 306486000 |
| Wednesday, January 1, 2020 | 6953000 | 353874000 |
| Friday, January 1, 2021 | 7778000 | 365978000 |
| Saturday, January 1, 2022 | 51174000 | 401858000 |
| Sunday, January 1, 2023 | 266718000 | 482375000 |
| Monday, January 1, 2024 | 363641000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, Ascendis Pharma A/S and Corcept Therapeutics Incorporated have charted distinct paths over the past decade. From 2014 to 2023, Corcept Therapeutics has consistently outperformed Ascendis Pharma in terms of revenue, showcasing a robust growth trajectory. Starting with a modest revenue of approximately $27 million in 2014, Corcept Therapeutics saw a remarkable increase, reaching nearly $482 million by 2023. This represents an impressive growth of over 1,700%.
In contrast, Ascendis Pharma began with a revenue of around $14 million in 2014, experiencing a significant surge to approximately $267 million by 2023. This growth, while substantial at over 1,800%, still trails behind Corcept's overall revenue figures. The data highlights the dynamic nature of the biotech industry, where strategic decisions and market positioning can lead to varied financial outcomes.
Revenue Showdown: AbbVie Inc. vs Ascendis Pharma A/S
Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated: Examining Key Revenue Metrics
Revenue Insights: United Therapeutics Corporation and Ascendis Pharma A/S Performance Compared
Breaking Down Revenue Trends: Dr. Reddy's Laboratories Limited vs Corcept Therapeutics Incorporated
R&D Spending Showdown: Ascendis Pharma A/S vs Corcept Therapeutics Incorporated
Comparing Revenue Performance: Ascendis Pharma A/S or Celldex Therapeutics, Inc.?
Revenue Showdown: Ascendis Pharma A/S vs Xencor, Inc.
Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated: A Comprehensive Revenue Analysis
Revenue Insights: Grifols, S.A. and Corcept Therapeutics Incorporated Performance Compared
Revenue Insights: Corcept Therapeutics Incorporated and Veracyte, Inc. Performance Compared
Corcept Therapeutics Incorporated vs Merus N.V.: Examining Key Revenue Metrics
Corcept Therapeutics Incorporated vs Evotec SE: Annual Revenue Growth Compared